These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11178407)

  • 1. Investigation about development of alternative efficacy verifications of swine erysipelas vaccines.
    Gyra H; Volmer R; Hausleithner D
    ALTEX; 1994; 11(5):46-54. PubMed ID: 11178407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Batch potency testing of inactivated erysipelas vaccines by ELISA--development, validation and implementation.
    Rosskopf-Streicher U; Johannes S; Gyra H; Beckmann R; Cussler K
    Dev Biol (Basel); 2002; 111():153-8. PubMed ID: 12678235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
    Cussler K; Balks E
    ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency Testing of Erysipelas Vaccines in Mice. ELISA vs. Challenge.
    Beckmann R; Cussler K
    ALTEX; 1994; 11(5):39-45. PubMed ID: 11178406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
    Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
    Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
    ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency Testing of Swine Erysipelas Vaccines by Serology Results of a Pre-validation Study.
    Rosskopf-Streicher U; Johannes S; Wilhelm M; Gyra H; Cussler K
    ALTEX; 1999; 16(3):123-128. PubMed ID: 11107318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U; Noeske K; Werner E
    ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency testing of inactivated erysipelas vaccines by ELISA--influence of the adjuvant on antibody development.
    Rosskopf-Streicher U; Johannes S; Cussler K
    Dev Biol (Basel); 2002; 111():159-62. PubMed ID: 12678236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test.
    Rosskopf-Streicher U; Johannes S; Wilhelm M; Cussler K
    Vaccine; 2001 Jan; 19(11-12):1477-83. PubMed ID: 11163671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A method for distinguishing infected from vaccinated pigs as a basis for the control of Aujeszky's disease].
    van Oirschot JT
    Tijdschr Diergeneeskd; 1988 Jan; 113(1):19-27. PubMed ID: 2829384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative investigations of a combined vaccine against parvovirus and erysipelas and corresponding monovaccines in different vaccination schedules. 1: Field trial].
    Ritzmann M; Gerbermann H; Gyra H; Eichinger HM; Heinritzi K
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 1999 May; 27(3):168-74. PubMed ID: 10384706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.
    Tignon M; Kulcsár G; Haegeman A; Barna T; Fábián K; Lévai R; Van der Stede Y; Farsang A; Vrancken R; Belák K; Koenen F
    Vet Microbiol; 2010 Apr; 142(1-2):59-68. PubMed ID: 19857935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan.
    Chen SP; Ellis TM; Lee MC; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR
    Vet Microbiol; 2007 Jan; 119(2-4):164-72. PubMed ID: 17112687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The usefulness of ELISA test for early serological detection of Trichinella spp. infection in pigs].
    Bień J
    Wiad Parazytol; 2007; 53(2):149-51. PubMed ID: 17912813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.